Health & BiotechNovo Nordisk Exits Cell Therapy, Hands Parkinson's Program to AI Startup as NVIDIA Locks In Global Pharma DealsSalvado•Jun 5, 2026
Business & FinanceEli Lilly Crosses $20B in 2026 Acquisitions as AI Rewrites Pharma's Global Deal LogicSalvado•May 31, 2026
Health & ScienceNVIDIA Locks Global Pharma Into AI Drug Discovery as Novo Nordisk Surges 24.9%Salvado•May 31, 2026
Health & ScienceNovo Nordisk Shares Surge 24.9% as Global Pharma Abandons Wet Labs for AISalvado•May 13, 2026
Healthcare InnovationAI-Designed Drug Candidates Show Clinical Progress Across US and Canadian TrialsSalvado•Mar 24, 2026
